We are live on
!
Find out more
MP
MSD Partners Portfolio holdings
AUM
$82.3M
1-Year Est. Return
15.13%
This Fund
S&P 500
This Quarter
Est. Return
-7.98%
1 Year Est. Return
-15.13%
3 Year Est. Return
-8.08%
5 Year Est. Return
-28.09%
10 Year Est. Return
+16.55%
AUM
$745M
AUM Growth
-$79.3M
(-9.6%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
90.76%
Holding
34
New
8
Increased
1
Reduced
2
Closed
7
Top Buys
| 1 |
Alaunos Therapeutics
TCRT
|
+$22M |
| 2 |
VCNX
Vaccinex, Inc. Common Stock
VCNX
|
+$6.57M |
| 3 |
iHeartMedia
IHRT
|
+$280K |
Top Sells
| 1 |
PG&E
PCG
|
+$61.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$52.6M |
| 3 |
AGN
Allergan plc
AGN
|
+$13.4M |
| 4 |
BWX Technologies
BWXT
|
+$10.2M |
| 5 |
Marten Transport
MRTN
|
+$4.99M |
Sector Composition
| 1 | Industrials | 34.73% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.71% |
| 4 | Financials | 7.86% |
| 5 | Energy | 4.58% |
Similar funds
FLC
1C
APW
VPW
KL
BCM
WAG
BC
MSD Partners's Q3 2019 Portfolio in Review
As of Q3 2019, MSD Partners held 34 positions worth $745M, down 9.6% from $825M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
MSD Partners's Q3 2019 filing shows 8 new, 1 increased, 2 reduced and 7 closed positions. Its largest new stake was Vaccinex, Inc. Common Stock: 5,836 shares worth $8.79M. The largest sale was PG&E, an estimated $61.3M.
By sector, the portfolio is most concentrated in Industrials at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
- MSD Partners's largest Q3 2019 buy was Vaccinex, Inc. Common Stock: 5,836 shares worth $8.79M.
- MSD Partners added most to Alaunos Therapeutics in Q3 2019, an estimated $22M increase.
- MSD Partners's biggest Q3 2019 reduction was Marten Transport, cutting an estimated $4.99M.
- MSD Partners fully exited PG&E in Q3 2019, selling an estimated $61.3M.
- MSD Partners's ten largest holdings make up 91% of its $745M portfolio in Q3 2019.
- MSD Partners opened 8 new positions and closed 7 in Q3 2019.
- MSD Partners's portfolio value fell 9.6% quarter-over-quarter to $745M.
Based on MSD Partners's 13F filing for Q3 2019, filed 14 Nov 2019.